1-3 of 3
Yasuyuki Iuchi
Close
Sort by
Journal Articles

Inhibition of Phosphorylation of ERK in CLL Cells Pre-Treatment Correlates Best with Response to Dasatinib, Fludarabine, and Rituximab for Patients with Relapsed CLL

Philip C. Amrein, MD, Xin Kai, Yasuyuki Iuchi, Jon Arnason, MD, Jennifer R. Brown, MD PhD, Karen K. Ballen, MD, Eyal C. Attar, MD, Amir T Fathi, Ephraim P. Hochberg, HyukJoo Hwang, Shiv Pillai
Journal: Blood
Blood (2014) 124 (21): 3636.
https://doi.org/10.1182/blood.V124.21.3636.3636
Published: 2014
Journal Articles

Increased Angiogenic Property Of Human Peripheral Blood Monocytes By ex Vivo Culture With c-Mpl Agonists In Hindlimb Ischemia Mouse Model

Junpei Sasajima, M.D, Ph.D, Toru Kawamoto, M.D, Ph.D, Yoshiaki Sugiyama, M.D, Ph.D, Yusuke Mizukami, Yasuyuki Iuchi, M.D, Ph.D, Toshifumi Ashida, M.D, Ph.D, Hiroki Tanabe, M.D, Ph.D, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1062.
https://doi.org/10.1182/blood.V122.21.1062.1062
Published: 2013
Journal Articles

Combined Use of Dendritic Cells Enhances Specific Anti-Leukemia Effect of Leukemia Cell-Derived-HSP70 in a Mouse Model with Minimal Residual Leukemia Cells.

Kazuya Sato, MD, PhD, Yoshihiro Torimoto, MD, PhD, Yasuyuki Iuchi, MD, PhD, Yasuaki Tamura, MD, PhD, Junko Jimbo, MD, Junki Inamura, MD, Motohiro Shindo, MD, PhD, Katsuya Ikuta, MD, PhD, Yutaka Kohgo, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 3065.
https://doi.org/10.1182/blood.V104.11.3065.3065
Published: 2004